Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
25,296
Sort by:
Clinical Trials Market Forecasts to 2034 – Global Analysis By Phase (Phase I, Phase II, Phase III, and Phase IV), Study Design (Interventional Studies, Observational Studies, and Expanded Access Trials), Indication (Therapeutic Area), Intervention Type, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Clinical Trials Market is accounted for $87.3 billion in 2026 and is expected to reach $160.4 billion by 2034 growing at a CAGR of 7.9% during the forecast per...
May 2026
200 pages
Immunotherapy Market Forecasts to 2034 – Global Analysis By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines, Cell-based Therapies, Cytokine-based Therapies, Oncolytic Virus Therapy, and Other Therapy Types), Route of Administration, Application, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Immunotherapy Market is accounted for $246.3 billion in 2026 and is expected to reach $555.4 billion by 2034 growing at a CAGR of 10.7% during the forecast per...
May 2026
200 pages
Vaccine Market Forecasts to 2034 – Global Analysis By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines, Viral Vector Vaccines, DNA Vaccines, and Combination Vaccines), Valency Type, Disease Indication, Route of Administration, Age Group, Manufacturing Model, Storage & Logistics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Vaccine Market is accounted for $91.4 billion in 2026 and is expected to reach $155.9 billion by 2034 growing at a CAGR of 6.9% during the forecast period. Vac...
May 2026
200 pages
Global Polymyxin B Market Growth 2026-2032
US$ 3,660.00
The global Polymyxin B market size is predicted to grow from US$ 55.37 million in 2025 to US$ 47.60 million in 2032; it is expected to grow at a CAGR of -2.2% from 2026 to 2032. Polymyxin B is a catio...
May 2026
94 pages
Anti-Infective Drugs Market - 2026-2033
US$ 3,400.00
Anti-Infective Drugs Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Anti-Infective Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
May 2026
46 pages
GM1 Gangliosidosis Treatment Market - 2026-2033
US$ 3,400.00
GM1 Gangliosidosis Treatment Market reached USD 186.26 million in 2025 and is expected to reach USD 626.86 million by 2033, growing with a CAGR of 16.60% during the forecast period 2026-2033. The GM1...
May 2026
54 pages
Global Meropenem for Injection Market Growth 2026-2032
US$ 3,660.00
The global Meropenem for Injection market size is predicted to grow from US$ 1804 million in 2025 to US$ 2443 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032. Meropenem for...
May 2026
96 pages
Global Modified NSAIDs Market Growth 2026-2032
US$ 3,660.00
The global Modified NSAIDs market size is predicted to grow from US$ 7169 million in 2025 to US$ 12144 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. Modified nonsteroida...
May 2026
153 pages
Fabry Disease Treatment Market - 2026-2033
US$ 3,400.00
Fabry Disease Treatment Marketis is growing with a CAGR of 7.40% during the forecast period 2026-2035. The Fabry Disease Treatment Market emerges as a key focus in DataM Intelligence latest in-depth a...
May 2026
49 pages
Wilsons Disease Treatment Market - 2026-2033
US$ 3,400.00
Wilsons Disease Treatment Market reached US$ 667.1 million in 2025 and is expected to reach US$ 1,022.4 million by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Wilsons...
May 2026
51 pages
Diabetes Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, Indication By Study Design, By Service (Protocol Designing, Site Identification), By Sponsor, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Diabetes Clinical Trials Market The global diabetes clinical trials market size was estimated at USD 5.1 billion in 2025 and is projected to reach USD 9.3 billion by 2033, growing at a CAGR of 7.9% fr...
May 2026
150 pages
Beta Thalassemia Market - 2026-2033
US$ 3,400.00
Beta Thalassemia Market reached US$ 560.97 million in 2025 and is expected to reach US$ 1,038.73 million by 2033, growing with a CAGR of 8.10% during the forecast period 2026-2033. The Beta Thalassemi...
May 2026
42 pages
Pain Relief Medication Market - 2026-2033
US$ 3,400.00
Pain Relief Medication Market reached USD 84.48 billion in 2025 and is expected to reach USD 128.86 billion by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Pain Relief...
May 2026
48 pages
Beri Beri Treatment Market - 2026-2033
US$ 3,400.00
Beri Beri Treatment Market reached USD 276.26 million in 2025 and is expected to reach USD 718.85 million by 2035, growing with a CAGR of 7.00% during the forecast period 2026-2035. The Beri Beri Trea...
May 2026
45 pages
Neutropenia Treatment Market - 2026-2033
US$ 3,400.00
Neutropenia Treatment Market reached USD 16.25 billion in 2025 and is expected to reach USD 26.46 billion by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Neutropenia Tr...
May 2026
47 pages
Pellagra Treatment Market - 2026-2033
US$ 3,400.00
Pellagra Treatment Market reached USD 56.26 million in 2025 and is expected to reach USD 96.60 million by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Pellagra Treatmen...
May 2026
44 pages
Porphyria Treatment Market - 2026-2033
US$ 3,400.00
Porphyria Treatment Market reached USD 1.26 billion in 2025 and is expected to reach USD 2.56 billion by 2033, growing with a CAGR of 9.20% during the forecast period 2026-2033. The Porphyria Treatmen...
May 2026
45 pages
Sarcopenia Treatment Market - 2026-2033
US$ 3,400.00
Sarcopenia Treatment Market reached USD 3.36 billion in 2025 and is expected to reach USD 5.56 billion by 2033, growing with a CAGR of 5.80% during the forecast period 2026-2033. The Sarcopenia Treatm...
May 2026
46 pages
Chronic Pain Treatment Market - 2026-2033
US$ 3,400.00
Chronic Pain Treatment Market reached US$ 55.94 billion in 2025 and is expected to reach US$ 140 billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Chronic Pain Tr...
May 2026
48 pages
Intra-Dialytic Hypotension (IDH) Market - 2026-2033
US$ 3,400.00
Intra-Dialytic Hypotension (IDH) Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Intra-Dialytic Hypotension (IDH) Market emerges as a key focus in DataM Intelligence...
May 2026
58 pages
Enclomiphene Market Size, Share & Trends Analysis Report By Product Type (Enclomiphene Citrate Tablets), By Dosage Strength (Medium Dose (12.5 mg - 25 mg)), By Indication, By Distribution Channel, By Region (North America, Europe, Asia Pacific, Middle East & Africa), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Enclomiphene Market The global enclomiphene market size was estimated at USD 216.00 million in 2025 and is projected to reach USD 419.05 million by 2033, growing at a CAGR of 8.70% from 2026 to 2033....
May 2026
150 pages
Global Curative Therapeutics Market - 2026-2033
US$ 3,400.00
Global Curative Therapeutics Market reached US$ 21.83 Billion in 2025 and is expected to reach US$ 44.95 Billion by 2033, growing with a CAGR of 9.50% during the forecast period 2026-2033. The Global...
May 2026
54 pages
Anti-senescence Therapeutics Market - 2026-2033
US$ 3,400.00
Anti-senescence Therapeutics Market reached US$ 33.03 billion in 2025 and is expected to reach US$ 53.39 billion by 2033, growing with a CAGR of 6.70% during the forecast period 2026-2033. The Anti-se...
May 2026
54 pages
Longevity And Wellness Pharmaceutical Market Size, Share & Trends Analysis Report By Type (Small Molecule Pharmaceutical Drugs, Biologics & Advanced Therapeutics, Nutraceuticals & Non-Prescription Longevity Compounds), By Therapeutic Application, By Route of Administration, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Longevity And Wellness Pharmaceutical Market The global longevity and wellness pharmaceutical market size was estimated at USD 63,400.00 million in 2025 and is projected to reach USD 106,008.42 millio...
May 2026
150 pages
Patient Derived Xenograft (PDX) Models Market - 2026-2033
US$ 3,400.00
Patient Derived Xenograft (PDX) Models Marketis is growing with a CAGR of 12.70% during the forecast period 2026-2035. The Patient Derived Xenograft (PDX) Models Market emerges as a key focus in DataM...
May 2026
64 pages
Mucopolysaccharidoses Market - 2026-2033
US$ 3,400.00
Mucopolysaccharidoses Market reached US$ 2,486.6 million in 2025 and is expected to reach US$ 4,389.85 million by 2033, growing with a CAGR of 7.50% during the forecast period 2026-2033. The Mucopolys...
May 2026
47 pages
Europe Cannabidiol Market Size, Share & Trends Analysis Report By Source (Hemp Derived CBD, Marijuana Derived CBD), By Product, Pharmaceutical-grade CBD), By Application, By Formulation, By Distribution Channel, By Country, And Segment Forecasts, 2026 - 2033
US$ 4,950.00
Europe Cannabidiol Market The Europe cannabidiol market size was estimated at USD 2.3 billion in 2025 and is projected to reach USD 6.0 billion by 2033, growing at a CAGR of 12.7% from 2026 to 2033. T...
May 2026
80 pages
Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Synthesis (Biotech, Fermentation, Plant Extracts, Synthetic), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Active Pharmaceutical Ingredient (API) Market is anticipated to expand from USD 160.91 billion in 2025 to USD 241.21 billion by 2031, exhibiting a compound annual growth rate of 6.98%. APIs...
May 2026
177 pages
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Vaginal and Vulvar Cancers, Anal Cancer, Oropharyngeal (Head and Neck) Cancers, Genital Warts), By Distribution Channel (Hospitals and Retail Pharmacies, Government Suppliers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for Human Papillomavirus vaccines is anticipated to expand from USD 8.47 Billion in 2025 to USD 14.12 Billion by 2031, experiencing a compound annual growth rate of 8.89%. HPV vaccin...
May 2026
180 pages
